Kirstine N Bojsen-Møller, Carsten Dirksen, Nils Bruun Jørgensen, Siv Hesse Jacobsen, Annette Karen Lundbeck Serup, Peter Hjorth Albers, Dorte L Hansen, Dorte Worm, Lars Naver, Viggo B Kristiansen, Jørgen Wojtaszewski, Bente Kiens, Jens J Holst, Erik Richter, Sten Madsbad
Roux-en-Y gastric bypass (RYGB) improves glycemic control within days after surgery, and changes in insulin sensitivity and beta-cell function are likely to be involved. We studied 10 obese patients with type 2 diabetes and 10 obese glucose tolerant subjects before, 1 week, 3 months and 1 year after RYGB. Participants were included after a preoperative diet induced total weight loss of -9.2±1.2%. Hepatic and peripheral insulin sensitivity were assessed using the hyperinsulinemic euglycemic clamp combined with glucose tracer technique and beta-cell function evaluated in response to an intravenous glucose-glucagon challenge as well as an oral glucose load. Already within 1 week, RYGB reduced basal glucose production, improved basal hepatic insulin sensitivity and increased insulin clearance highlighting the liver as an important organ responsible for the early effects on glucose metabolism after surgery. Insulin mediated glucose disposal and suppression of fatty acids did not improve immediately after surgery but increased at 3 months and 1 year likely related to the reduction in body weight. Insulin secretion increased after RYGB, but only in patients with type 2 diabetes and only in response to oral glucose, underscoring the importance of the changed gut anatomy.
|Number of pages||13|
|Publication status||Published - 2014|